Stock listing
Axogen, Inc.
Selected listing: AXGN · NASDAQ · USD · US
Axogen, Inc. (NASDAQ:AXGN), Health Technology. Latest release Oct 1, 2026: Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™…
- Ticker
- NASDAQ:AXGN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Axogen, Inc.
Axogen, Inc. is a public company traded under the ticker AXGN in the American market. Axogen specializes in regenerative medicine for peripheral nerves, focusing on providing innovative solutions for nerve repair and regeneration.
Latest news from Axogen, Inc.
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
October 1, 2026
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
September 10, 2026
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
September 10, 2026
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
September 1, 2026
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology
July 29, 2026
Events
Research Axogen, Inc.
Alternate listings
AXGN:BOATS
US · USD
Alternate listing for Axogen, Inc.; the primary context on this page is AXGN:NASDAQ.
A1JMHK:LS
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is AXGN:NASDAQ.
0HKD:LSE
GB · USD
Alternate listing for Axogen, Inc.; the primary context on this page is AXGN:NASDAQ.
LT3:FWB
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is AXGN:NASDAQ.
LT3:TRADEGATE
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is AXGN:NASDAQ.
LT3:SWB
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is AXGN:NASDAQ.